SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-023905
Filing Date
2023-06-29
Accepted
2023-06-29 16:13:09
Documents
16
Period of Report
2023-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mltx-20230627.htm   iXBRL 8-K 36801
2 EX-1.1 exhibit11-8xk.htm EX-1.1 309016
3 EX-5.1 exhibit51-8xk.htm EX-5.1 45531
8 walkerslogo1.jpg GRAPHIC 13511
  Complete submission text file 0001628280-23-023905.txt   645248

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mltx-20230627.xsd EX-101.SCH 2276
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mltx-20230627_def.xml EX-101.DEF 14998
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mltx-20230627_lab.xml EX-101.LAB 28767
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mltx-20230627_pre.xml EX-101.PRE 15565
10 EXTRACTED XBRL INSTANCE DOCUMENT mltx-20230627_htm.xml XML 4405
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39630 | Film No.: 231057528
SIC: 2834 Pharmaceutical Preparations